Dwight D Blake MD

Internal Medicine•Union City, GA

Internal medicine at Rophe Adult & Pediatric Medicine

Join to View Full Profile

4910 Jonesboro RdBldg. 700, Ste. 1Union City, GA 30291
Phone+1 770-964-7736
Fax+1 770-306-1726

Education & Training

University of Miami/Jackson Health SystemResidency, Internal Medicine, 1984 - 1987
State University of New York Downstate Medical Center College of MedicineClass of 1984

Certifications & Licensure

GA State Medical License 2002 - 2027
FL State Medical License 1986 - 2005

Awards, Honors, & Recognition

Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012

Clinical Trials

A Phase 2 Study of LY3209590 in Participants With Type 2 Diabetes Mellitus Start of enrollment: 2020 Jul 01
Completed
Phase 2
A Donanemab (LY3002813) Prevention Study in Participants With Alzheimer's Disease (TRAILBLAZER-ALZ 3) Start of enrollment: 2021 Aug 27
Recruiting
Phase 3
A Study of Insulin Efsitora Alfa (LY3209590) Compared to Degludec in Adults With Type 2 Diabetes Who Are Starting Basal Insulin for the First Time Start of enrollment: 2022 Jun 03
COMPLETED
PHASE3
A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight for the Maintenance of Weight Loss Start of enrollment: 2021 Mar 29
Completed
Phase 3
A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Not Controlled With Diet and Exercise Alone Start of enrollment: 2019 Jun 03
Completed
Phase 3
A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity Start of enrollment: 2022 Oct 11
ACTIVE_NOT_RECRUITING
PHASE3
EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Years of Age With COVID-19 That Are Not Hospitalized But Are at Risk for Severe Disease Start of enrollment: 2022 Mar 07
RECRUITING
PHASE2, PHASE3
A Study to Evaluate a Modified RNA Vaccine Against Influenza in Adults 18 Years of Age or Older Start of enrollment: 2022 Sep 12
Completed
Phase 3
A Study of Insulin Efsitora Alfa (LY3209590) Compared With Insulin Degludec in Participants With Type 2 Diabetes Currently Treated With Basal Insulin Start of enrollment: 2022 Mar 08
Completed
Phase 3
Evaluation of the ctDNA LUNAR Test in an Average Patient Screening Episode Start of enrollment: 2019 Oct 08
ACTIVE_NOT_RECRUITING
A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk Start of enrollment: 2023 Apr 03
ACTIVE_NOT_RECRUITING
PHASE3
A Study of Tirzepatide (LY3298176) Versus Insulin Degludec in Participants With Type 2 Diabetes Start of enrollment: 2019 Apr 01
Completed
Phase 3
A Study of Tirzepatide (LY3298176) Versus Semaglutide Once Weekly as Add-on Therapy to Metformin in Participants With Type 2 Diabetes Start of enrollment: 2019 Jul 30
Completed
Phase 3
A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children Start of enrollment: 2022 Sep 23
Recruiting
Phase 2, Phase 3
An Efficacy and Safety Study w/ Azstarys® in Children With ADHD Start of enrollment: 2023 Mar 22
COMPLETED
PHASE4
A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight With Weight Related Comorbidities Start of enrollment: 2023 Apr 21
COMPLETED
PHASE3
A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight Start of enrollment: 2019 Dec 04
COMPLETED
PHASE3
Join now to see all